Zomedica Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019	2018	2017	2016
Market Capitalization	139	196	160	300	130	36	117	177	-
Market Cap Growth	-	22.82%	-46.82%	130.90%	263.72%	-69.33%	-33.99%	-	-
Enterprise Value	51	108	46	107	70	35	115	173	-3
PE Ratio	-5.83	-5.83	-8.94	-16.34	-7.69	-1.81	-7.00	-21.90	-
PS Ratio	5.53	7.79	8.44	72.67	-	-	-	-	-
PB Ratio	0.58	0.82	0.60	1.11	2.55	17.07	31.88	40.26	-
P/FCF Ratio	-7.18	-7.18	-11.23	-20.82	-8.01	-2.26	-9.91	-24.31	-
P/OCF Ratio	-12.28	-12.28	-13.69	-21.04	-8.01	-2.29	-10.46	-24.90	-
EV/Sales Ratio	2.04	4.30	2.45	25.83	-	-	-	-	-
EV/EBITDA Ratio	-3.19	-3.19	-2.34	-5.22	-4.21	-1.86	-6.97	-21.72	0.57
EV/EBIT Ratio	-3.12	-3.12	-2.29	-5.16	-4.14	-1.78	-6.89	-21.47	0.56
EV/FCF Ratio	-3.97	-3.97	-3.26	-7.40	-4.31	-2.23	-9.74	-23.84	0.67
Debt / Equity Ratio	0.01	0.01	0.01	0.01	0.04	-	-	-	0.00
Debt / EBITDA Ratio	-0.08	-0.08	-0.09	-0.07	-0.11	-	-	-	0.00
Debt / FCF Ratio	-0.10	-0.10	-0.12	-0.10	-0.12	-	-	-	0.00
Quick Ratio	10.26	10.26	14.97	45.10	30.63	0.24	0.82	4.19	4.38
Current Ratio	11.06	11.06	15.81	46.18	31.48	0.87	1.63	5.14	4.83
Asset Turnover	0.09	0.09	0.07	0.02	0	0	0	0	0
Interest Coverage	-198.82	-198.82	-20225.00	-3451.50	-23102.53	-1077.86	-	-	-
Return on Equity (ROE)	-13.10%	-13.10%	-6.70%	-6.70%	-49.70%	-612.00%	-446.00%	-196.20%	-158.40%
Return on Assets (ROA)	-12.40%	-12.40%	-6.40%	-6.60%	-42.10%	-302.40%	-309.20%	-164.70%	-141.10%
Return on Capital (ROIC)	-17.82%	-17.82%	-8.15%	-7.94%	-31.90%	-944.21%	-455.25%	-184.27%	-149.08%
Earnings Yield	-24.17%	-17.15%	-11.18%	-6.12%	-13.00%	-55.32%	-14.28%	-4.57%	-
FCF Yield	-19.63%	-13.92%	-8.90%	-4.80%	-12.48%	-44.15%	-10.09%	-4.11%	-
Buyback Yield / Dilution	-	-2.45%	-162.46%	-242.85%	-13.76%	-6.91%	-9.03%	-
Total Shareholder Return	-	-2.45%	-162.46%	-242.85%	-13.76%	-6.91%	-9.03%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).